Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innovex International (INVX) Other financing activities (2017 - 2025)

Innovex International (INVX) has disclosed Other financing activities for 15 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities fell 88.05% year-over-year to $1.2 million, compared with a TTM value of $1.5 million through Dec 2025, up 408.92%, and an annual FY2025 reading of $1.5 million, changed N/A over the prior year.
  • Other financing activities was $1.2 million for Q3 2025 at Innovex International, up from -$727000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $9.7 million in Q3 2024 and bottomed at -$10.2 million in Q4 2024.
  • Average Other financing activities over 5 years is $70647.1, with a median of -$11000.0 recorded in 2023.
  • The sharpest move saw Other financing activities soared 19725.0% in 2022, then crashed 1195.8% in 2024.
  • Year by year, Other financing activities stood at $4000.0 in 2021, then skyrocketed by 19725.0% to $793000.0 in 2022, then crashed by 199.12% to -$786000.0 in 2023, then plummeted by 1195.8% to -$10.2 million in 2024, then skyrocketed by 111.4% to $1.2 million in 2025.
  • Business Quant data shows Other financing activities for INVX at $1.2 million in Q3 2025, -$727000.0 in Q2 2025, and $1.0 million in Q1 2025.